Shilpa Medicare Limited
NSE: SHILPAMED BSE: SHILPAMED
NSE
827.60
-9.05 (-1.08%)
Prev Close
836.65
Open Price
838.95
Volume
90,322
Today Low / High
824.75 / 841.15
52 WK Low / High
555 / 1000
Range
786 - 869
BSE
827.30
-7.25 (-0.87%)
Prev Close
834.55
Open Price
838.05
Volume
3,960
Today Low / High
825 / 838.2
52 WK Low / High
530.5 / 1003.2
Range
786 - 869
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 827.6 (target range: 786 - 869), reflecting a change of -9.05 (-1.08169%). On the BSE, it is listed at 827.3 (target range: 786 - 869), showing a change of -7.25 (-0.86873%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
12 Sep
838.95
-1.35%
11 Sep
841.00
-0.52%
10 Sep
831.95
0.34%
09 Sep
860.00
-3.56%
08 Sep
838.90
1.05%
05 Sep
842.00
0.32%
04 Sep
848.00
-0.71%
03 Sep
841.00
0.41%
02 Sep
838.00
0.08%
01 Sep
849.00
0.17%
29 Aug
850.00
-0.44%
28 Aug
823.95
2.29%
26 Aug
850.00
-3.91%
25 Aug
854.80
-0.67%
22 Aug
859.45
-0.88%
21 Aug
864.80
-0.62%
20 Aug
874.00
-1.92%
19 Aug
866.50
0.15%
18 Aug
920.00
-4.01%
Shilpa Medicare Limited Graph
Shilpa Medicare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Shilpa Medicare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 827.60, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 827.30 | 835.57 | 752.02 - 919.13 |
| 843.85 | 675.08 - 1,012.62 | ||
| 852.12 | 596.48 - 1,107.75 | ||
| Bearish Scenario | 827.30 | 819.03 | 737.12 - 900.93 |
| 810.75 | 648.60 - 972.90 | ||
| 802.48 | 561.74 - 1,043.23 |
Overview of Shilpa Medicare Limited
ISIN
INE790G01031
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
81,223
Market Cap
80,931,748,840
Last Dividend
0
Official Website
IPO Date
2009-12-03
DCF Diff
1,819.55
DCF
-909
Financial Ratios Every Investor Needs
Stock Dividend of SHILPAMED
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-17 | September 17, 25 | 1 | 1 | 2025-09-17 | 2025-10-23 | |
| 2022-09-19 | September 19, 22 | 1.1 | 1.1 | 2022-09-20 | 2022-10-28 | |
| 2021-09-17 | September 17, 21 | 1.1 | 1.1 | 2021-09-21 | 2021-10-28 | |
| 2020-03-16 | March 16, 20 | 1.1 | 1.1 | 2020-03-17 | 2020-04-05 | 2020-03-03 |
| 2019-09-12 | September 12, 19 | 1 | 1 | 2019-09-13 | 2019-10-20 | 2019-05-27 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,286.41 Cr | 410.37 Cr | 876.04 Cr | 0.6810 | 0.00 Cr | 0.00 Cr | 204.06 Cr | 78.29 Cr | 8.04 | 310.86 Cr | 0.0609 |
| 2024-03-31 | 1,153.11 Cr | 443.53 Cr | 709.57 Cr | 0.6154 | 30.96 Cr | 299.59 Cr | 376.16 Cr | 31.87 Cr | 3.67 | 245.94 Cr | 0.0276 |
| 2023-03-31 | 1,043.45 Cr | 416.84 Cr | 626.60 Cr | 0.6005 | 49.10 Cr | 29.53 Cr | -4.60 Cr | -32.53 Cr | -3.75 | 113.47 Cr | -0.0312 |
| 2022-03-31 | 1,140.05 Cr | 384.10 Cr | 755.95 Cr | 0.6631 | 55.06 Cr | 55.23 Cr | 125.83 Cr | 60.66 Cr | 7.26 | 226.89 Cr | 0.0532 |
| 2021-03-31 | 900.16 Cr | 270.77 Cr | 629.39 Cr | 0.6992 | 33.81 Cr | 35.72 Cr | 119.30 Cr | 147.78 Cr | 18.13 | 272.63 Cr | 0.1642 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 25.97 Cr | 3,310.71 Cr | 947.01 Cr | 2,372.2364 Cr | 587.75 Cr | 561.78 Cr | 347.93 Cr | 1,674.96 Cr | 0.00 Cr | 0.00 Cr | 40.79 Cr | 674.2322 Cr |
| 2024-03-31 | 30.23 Cr | 3,093.20 Cr | 1,293.25 Cr | 1,808.6941 Cr | 937.39 Cr | 907.16 Cr | 344.93 Cr | 1,638.50 Cr | 0.01 Cr | 0.00 Cr | 39.91 Cr | 693.3482 Cr |
| 2023-03-31 | 21.32 Cr | 2,903.93 Cr | 1,129.57 Cr | 1,783.2770 Cr | 797.89 Cr | 776.57 Cr | 319.82 Cr | 1,537.49 Cr | 0.00 Cr | 17.48 Cr | 53.56 Cr | 784.4477 Cr |
| 2022-03-31 | 33.83 Cr | 2,875.50 Cr | 1,064.35 Cr | 1,822.1948 Cr | 683.29 Cr | 649.46 Cr | 355.24 Cr | 1,491.38 Cr | 25.02 Cr | 19.27 Cr | 0.00 Cr | 611.5362 Cr |
| 2021-03-31 | 122.85 Cr | 2,632.37 Cr | 1,164.87 Cr | 1,478.6666 Cr | 845.93 Cr | 723.09 Cr | 316.84 Cr | 1,330.82 Cr | 7.48 Cr | 17.80 Cr | 0.00 Cr | 603.5029 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 132.1786 Cr | -199.0848 Cr | 62.6537 Cr | -111.4554 Cr | -3.2323 Cr | 28.5237 Cr | -243.6340 Cr | 122.3329 Cr | -349.1709 Cr | 0.0000 Cr | -22.3156 Cr |
| 2024-03-31 | 135.3384 Cr | -166.5844 Cr | 139.1440 Cr | -49.2221 Cr | 11.3540 Cr | 30.4254 Cr | -184.5605 Cr | 31.8742 Cr | 139.6718 Cr | 0.0000 Cr | -25.1071 Cr |
| 2023-03-31 | 179.9236 Cr | -232.6122 Cr | 45.7981 Cr | -46.7438 Cr | -6.5509 Cr | 19.0714 Cr | -226.6674 Cr | -38.2795 Cr | -27.9970 Cr | -9.5482 Cr | 35.4173 Cr |
| 2022-03-31 | 105.1333 Cr | -285.4984 Cr | 82.8583 Cr | -226.6928 Cr | -97.5067 Cr | 25.3391 Cr | -331.8261 Cr | 102.2648 Cr | -163.0498 Cr | -8.9680 Cr | -38.4010 Cr |
| 2021-03-31 | 46.9278 Cr | -404.2761 Cr | 436.3741 Cr | -307.3143 Cr | 79.0259 Cr | 123.3402 Cr | -354.2421 Cr | 195.0519 Cr | 458.6544 Cr | 0.0000 Cr | -106.3432 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 321.46 Cr | 79.61 Cr | 241.85 Cr | 0.7524 | 62.72 Cr | 46.89 Cr | 4.79 | 97.28 Cr | 0.1459 |
| 2025-03-31 | 330.79 Cr | 104.47 Cr | 226.32 Cr | 0.6842 | 47.96 Cr | 14.51 Cr | 1.48 | 58.56 Cr | 0.0439 |
| 2024-12-31 | 319.32 Cr | 91.00 Cr | 228.31 Cr | 0.7150 | 51.88 Cr | 31.78 Cr | 3.25 | 81.82 Cr | 0.0995 |
| 2024-09-30 | 343.80 Cr | 121.98 Cr | 221.82 Cr | 0.6452 | 57.72 Cr | 17.94 Cr | 1.83 | 90.61 Cr | 0.0522 |
| 2024-06-30 | 292.51 Cr | 192.06 Cr | 100.46 Cr | 0.3434 | 46.49 Cr | 14.06 Cr | 1.46 | 79.52 Cr | 0.0481 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 25.97 Cr | 32.59 Cr | 58.56 Cr | 440.84 Cr | 347.93 Cr | 985.67 Cr | 1,674.96 Cr | 3,310.71 Cr | 947.01 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 17.17 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -2,319.18 Cr |
| 2024-09-30 | 17.01 Cr | 19.51 Cr | 36.52 Cr | 359.83 Cr | 326.55 Cr | 859.04 Cr | 1,623.37 Cr | 3,117.33 Cr | 798.14 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 30.44 Cr | 0.00 Cr | 0.00 Cr | 30.44 Cr | 0.00 Cr | 0.00 Cr | -1,799.96 Cr |
| 2024-03-31 | 30.23 Cr | 0.00 Cr | 30.23 Cr | 392.05 Cr | 344.93 Cr | 876.83 Cr | 1,596.19 Cr | 3,093.20 Cr | 1,293.25 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 14.51 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 31.78 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 17.94 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 14.06 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 24.50 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2025-10-03 | October 03, 25 | 2:1 |
| 2025-09-26 | September 26, 25 | 2:1 |
| 2015-11-06 | November 06, 15 | 2:1 |
| 2013-07-16 | July 16, 13 | 3:2 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,616.60 | ₹3,878,676,048,000.00 | ₹1,878,887.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,026.50 | ₹1,599,848,928,500.00 | ₹487,570.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,566.20 | ₹1,206,962,559,000.00 | ₹139,352.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,316.70 | ₹1,095,964,560,653.00 | ₹1,042,670.00 |
| Mankind Pharma Limited | MANKIND | ₹2,579.60 | ₹1,064,750,578,074.00 | ₹181,489.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹1,044.75 | ₹1,051,258,792,500.00 | ₹559,507.00 |
| Lupin Limited | LUPIN | ₹2,043.40 | ₹933,333,167,000.00 | ₹1,611,273.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,448.00 | ₹651,390,120,000.00 | ₹120,660.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,094.40 | ₹635,629,708,800.00 | ₹793,814.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,132.50 | ₹601,793,632,500.00 | ₹615,366.00 |
| Laurus Labs Limited | LAURUSLABS | ₹896.05 | ₹483,710,191,250.00 | ₹1,298,692.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹980.40 | ₹375,068,694,643.00 | ₹176,773.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,314.80 | ₹333,570,019,200.00 | ₹237,352.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,579.10 | ₹322,222,437,600.00 | ₹58,260.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,699.90 | ₹266,197,540,400.00 | ₹56,240.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,518.00 | ₹246,651,927,918.00 | ₹287,476.00 |
| Piramal Enterprises Limited | PEL | ₹1,083.70 | ₹245,650,948,600.00 | ₹565,474.00 |
| Eris Lifesciences Limited | ERIS | ₹1,675.90 | ₹228,269,311,300.00 | ₹711,885.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,003.50 | ₹225,087,500,000.00 | ₹7,058.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹16,049.00 | ₹205,907,065,100.00 | ₹157,007.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹946.50 | ₹186,046,879,500.00 | ₹132,074.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,122.30 | ₹178,761,066,300.00 | ₹82,149.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,245.60 | ₹170,691,873,520.00 | ₹78,387.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹862.20 | ₹154,428,642,000.00 | ₹287,000.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹534.35 | ₹129,656,821,400.00 | ₹1,274,862.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,243.50 | ₹103,638,353,900.00 | ₹6,067.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹926.35 | ₹83,957,850,833.00 | ₹170,096.00 |
| Strides Pharma Science Limited | STAR | ₹909.75 | ₹83,854,113,825.00 | ₹182,119.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹827.60 | ₹80,931,748,840.00 | ₹90,322.00 |
| FDC Limited | FDC | ₹463.35 | ₹75,438,013,500.00 | ₹27,055.00 |
| Innova Captab Limited | INNOVACAP | ₹859.60 | ₹49,190,549,828.00 | ₹33,571.00 |
| Suven Life Sciences Limited | SUVEN | ₹224.63 | ₹48,978,481,767.00 | ₹179,307.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹509.65 | ₹46,515,755,500.00 | ₹129,437.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹143.10 | ₹46,439,098,200.00 | ₹131,426.00 |
| Sequent Scientific Limited | SEQUENT | ₹182.51 | ₹45,688,640,850.00 | ₹212,635.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,380.30 | ₹39,367,781,700.00 | ₹11,398.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹369.25 | ₹37,027,651,500.00 | ₹37,782.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹710.75 | ₹36,048,600,325.00 | ₹42,599.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹506.40 | ₹35,653,497,120.00 | ₹17,743.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹115.76 | ₹33,978,685,520.00 | ₹10,738,156.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹677.55 | ₹32,626,065,150.00 | ₹56,274.00 |
| Hikal Limited | HIKAL | ₹257.45 | ₹31,743,842,450.00 | ₹240,530.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹53.90 | ₹29,534,720,600.00 | ₹3,571,211.00 |
| Indoco Remedies Limited | INDOCO | ₹299.05 | ₹27,586,734,495.00 | ₹342,407.00 |
| Alembic Limited | ALEMBICLTD | ₹103.16 | ₹26,489,631,017.00 | ₹256,891.00 |
Key Executives
Company Secretary & Compliance Officer
Ms. Ritu Tiwary
Gender: female
Year Born: 1977
Senior Vice President Domestic Formulations and Biologics
Mr. Rajeev Saxena
Gender: male
Year Born: 1973
Executive Vice President Formulations for Small Molecules
Ms. Smita Holey
Gender: female
Year Born:
Vice President
Mr. Awez Mohinuddin Pathan
Gender: male
Year Born: 1970
Chief Financial Officer
Mr. Alpesh Maheshkumar Dalal
Gender: male
Year Born: 1976
Senior Vice President of Technical
Pramod Kumar
Gender: Not Specified
Year Born: 1963
MD & Director
Mr. Vishnukanth Chaturbhuj Bhutada B. Pharm
Gender: male
Year Born: 1962
Senior Vice President of Formulation
Mr. Abhay Sapre
Gender: male
Year Born: 1971
Chief Operating Officer of Formulations
Dr. Jayant Karajgi
Gender: Not Specified
Year Born: 1967
Vice President of Projects & Operations and Whole-Time Director
Mr. Sharath Reddy Kalakota M.Pharma
Gender: male
Year Born: 1967
FAQs about Shilpa Medicare Limited
Who is the CEO of the company?
The CEO is Vishnukanth Chaturbhuj Bhutada B. Pharm.
What is the current market price of the stock?
The current price is ₹827.60.
What is the 52-week price range?
The range is ₹555-1000.
What is the market capitalization of the company?
The market capitalization is ₹8,093.17 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 72.90.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Shilpa Medicare Limited (ISIN: INE790G01031) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹8,093.17 crores and an average daily volume of 81,223 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.